[Maintenance cimetidine treatment in duodenal ulcer disease. Second part: Side-effects and indications (author's transl)].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002927:Cimetidine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003221:Confusion / Q000139:chemically induced; D004285:Dogs; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004700:Endocrine System Diseases / Q000139:chemically induced; D005260:Female; D006146:Guanidines / Q000009:adverse effects*; D006801:Humans; D007154:Immune System Diseases / Q000139:chemically induced; D008297:Male; D013274:Stomach Neoplasms / Q000209:etiology
D006146:Guanidines; D002927:Cimetidine
Le traitement d'entretien de la maladie ulcéreuse duodénale par la cimétidine. 2e partie: Tolérance et indications.